Literature DB >> 22090129

Enhanced growth of influenza vaccine seed viruses in vero cells mediated by broadening the optimal pH range for virus membrane fusion.

Shin Murakami1, Taisuke Horimoto, Mutsumi Ito, Ryo Takano, Hiroaki Katsura, Masayuki Shimojima, Yoshihiro Kawaoka.   

Abstract

Vaccination is one of the most effective preventive measures to combat influenza. Prospectively, cell culture-based influenza vaccines play an important role for robust vaccine production in both normal settings and urgent situations, such as during the 2009 pandemic. African green monkey Vero cells are recommended by the World Health Organization as a safe substrate for influenza vaccine production for human use. However, the growth of influenza vaccine seed viruses is occasionally suboptimal in Vero cells, which places limitations on their usefulness for enhanced vaccine production. Here, we present a strategy for the development of vaccine seed viruses with enhanced growth in Vero cells by changing an amino acid residue in the stem region of the HA2 subunit of the hemagglutinin (HA) molecule. This mutation optimized the pH for HA-mediated membrane fusion in Vero cells and enhanced virus growth 100 to 1,000 times in the cell line, providing a promising strategy for cell culture-based influenza vaccines.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22090129      PMCID: PMC3264368          DOI: 10.1128/JVI.06009-11

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  44 in total

1.  Enhanced growth of seed viruses for H5N1 influenza vaccines.

Authors:  Taisuke Horimoto; Shin Murakami; Yukiko Muramoto; Shinya Yamada; Ken Fujii; Maki Kiso; Kiyoko Iwatsuki-Horimoto; Yoichiro Kino; Yoshihiro Kawaoka
Journal:  Virology       Date:  2007-07-24       Impact factor: 3.616

Review 2.  Vero cell platform in vaccine production: moving towards cell culture-based viral vaccines.

Authors:  P Noel Barrett; Wolfgang Mundt; Otfried Kistner; M Keith Howard
Journal:  Expert Rev Vaccines       Date:  2009-05       Impact factor: 5.217

3.  Structural characterization of an early fusion intermediate of influenza virus hemagglutinin.

Authors:  Rui Xu; Ian A Wilson
Journal:  J Virol       Date:  2011-03-02       Impact factor: 5.103

4.  Adaptation of egg-grown and transfectant influenza viruses for growth in mammalian cells: selection of hemagglutinin mutants with elevated pH of membrane fusion.

Authors:  Y P Lin; S A Wharton; J Martín; J J Skehel; D C Wiley; D A Steinhauer
Journal:  Virology       Date:  1997-07-07       Impact factor: 3.616

5.  Heterosubtypic neutralizing antibodies are produced by individuals immunized with a seasonal influenza vaccine.

Authors:  Davide Corti; Amorsolo L Suguitan; Debora Pinna; Chiara Silacci; Blanca M Fernandez-Rodriguez; Fabrizia Vanzetta; Celia Santos; Catherine J Luke; Fernando J Torres-Velez; Nigel J Temperton; Robin A Weiss; Federica Sallusto; Kanta Subbarao; Antonio Lanzavecchia
Journal:  J Clin Invest       Date:  2010-04-12       Impact factor: 14.808

6.  Avian flu: isolation of drug-resistant H5N1 virus.

Authors:  Q Mai Le; Maki Kiso; Kazuhiko Someya; Yuko T Sakai; T Hien Nguyen; Khan H L Nguyen; N Dinh Pham; Ha H Ngyen; Shinya Yamada; Yukiko Muramoto; Taisuke Horimoto; Ayato Takada; Hideo Goto; Takashi Suzuki; Yasuo Suzuki; Yoshihiro Kawaoka
Journal:  Nature       Date:  2005-10-20       Impact factor: 49.962

7.  Safety and immunogenicity of inactivated, Vero cell culture-derived whole virus influenza A/H5N1 vaccine given alone or with aluminum hydroxide adjuvant in healthy adults.

Authors:  Wendy A Keitel; Cornelia L Dekker; ChrisAnna Mink; James D Campbell; Kathryn M Edwards; Shital M Patel; Dora Y Ho; Helen K Talbot; Kuo Guo; Diana L Noah; Heather Hill
Journal:  Vaccine       Date:  2009-03-25       Impact factor: 3.641

Review 8.  From lethal virus to life-saving vaccine: developing inactivated vaccines for pandemic influenza.

Authors:  John M Wood; James S Robertson
Journal:  Nat Rev Microbiol       Date:  2004-10       Impact factor: 60.633

9.  Defective interfering influenza viruses and host cells: establishment and maintenance of persistent influenza virus infection in MDBK and HeLa cells.

Authors:  B K De; D P Nayak
Journal:  J Virol       Date:  1980-12       Impact factor: 5.103

10.  Glycosylation does not determine segregation of viral envelope proteins in the plasma membrane of epithelial cells.

Authors:  R F Green; H K Meiss; E Rodriguez-Boulan
Journal:  J Cell Biol       Date:  1981-05       Impact factor: 10.539

View more
  34 in total

1.  Recombinant influenza A H3N2 viruses with mutations of HA transmembrane cysteines exhibited altered virological characteristics.

Authors:  Jianqiang Zhou; Shun Xu; Jun Ma; Wen Lei; Kang Liu; Qiliang Liu; Yida Ren; Chunyi Xue; Yongchang Cao
Journal:  Virus Genes       Date:  2013-11-23       Impact factor: 2.332

Review 2.  Modulation of the pH Stability of Influenza Virus Hemagglutinin: A Host Cell Adaptation Strategy.

Authors:  Santiago Di Lella; Andreas Herrmann; Caroline M Mair
Journal:  Biophys J       Date:  2016-06-07       Impact factor: 4.033

3.  Identification of key hemagglutinin residues responsible for cleavage, acid stability, and virulence of fifth-wave highly pathogenic avian influenza A(H7N9) viruses.

Authors:  Xiangjie Sun; Jessica A Belser; Hua Yang; Joanna A Pulit-Penaloza; Claudia Pappas; Nicole Brock; Hui Zeng; Hannah M Creager; James Stevens; Taronna R Maines
Journal:  Virology       Date:  2019-07-12       Impact factor: 3.616

4.  Animal Cell Expression Systems.

Authors:  M Butler; U Reichl
Journal:  Adv Biochem Eng Biotechnol       Date:  2021       Impact factor: 2.635

5.  The matrix gene segment destabilizes the acid and thermal stability of the hemagglutinin of pandemic live attenuated influenza virus vaccines.

Authors:  Christopher D O'Donnell; Leatrice Vogel; Yumiko Matsuoka; Hong Jin; Kanta Subbarao
Journal:  J Virol       Date:  2014-08-13       Impact factor: 5.103

6.  Hemagglutinin Stability Regulates H1N1 Influenza Virus Replication and Pathogenicity in Mice by Modulating Type I Interferon Responses in Dendritic Cells.

Authors:  Marion Russier; Guohua Yang; Benoit Briard; Victoria Meliopoulos; Sean Cherry; Thirumala-Devi Kanneganti; Stacey Schultz-Cherry; Peter Vogel; Charles J Russell
Journal:  J Virol       Date:  2020-01-17       Impact factor: 5.103

7.  The C-type Lectin Langerin Functions as a Receptor for Attachment and Infectious Entry of Influenza A Virus.

Authors:  Wy Ching Ng; Sarah L Londrigan; Najla Nasr; Anthony L Cunningham; Stuart Turville; Andrew G Brooks; Patrick C Reading
Journal:  J Virol       Date:  2015-10-14       Impact factor: 5.103

8.  A histidine residue of the influenza virus hemagglutinin controls the pH dependence of the conformational change mediating membrane fusion.

Authors:  Caroline M Mair; Tim Meyer; Katjana Schneider; Qiang Huang; Michael Veit; Andreas Herrmann
Journal:  J Virol       Date:  2014-09-03       Impact factor: 5.103

9.  The pH of activation of the hemagglutinin protein regulates H5N1 influenza virus replication and pathogenesis in mice.

Authors:  Hassan Zaraket; Olga A Bridges; Charles J Russell
Journal:  J Virol       Date:  2013-02-28       Impact factor: 5.103

10.  Downregulating viral gene expression: codon usage bias manipulation for the generation of novel influenza A virus vaccines.

Authors:  Steven F Baker; Aitor Nogales; Luis Martínez-Sobrido
Journal:  Future Virol       Date:  2015-06       Impact factor: 1.831

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.